Format
Sort by

Send to:

Choose Destination

Search results

Items: 5

1.

Crystal form control and particle size control of RG3487, a nicotinic α7 receptor partial agonist.

Kuang S, Zhang P, Dong EZ, Jennings G, Zhao B, Pierce M.

Int J Pharm. 2016 May 7;508(1-2):109-122. doi: 10.1016/j.ijpharm.2016.04.066. [Epub ahead of print]

PMID:
27167333
2.

Setting occupational exposure limits for unstudied pharmaceutical intermediates using an in vitro parallelogram approach.

Maier MS.

Toxicol Mech Methods. 2011 Feb;21(2):76-85. doi: 10.3109/15376511003638280. Epub 2010 Feb 15.

PMID:
20156007
3.

Differentiating primary human cells in rapid-throughput discovery applications.

Marshak DR, Greenwalt DE.

Methods Mol Biol. 2007;356:121-8.

PMID:
16988399
4.

Kinetic characterization and in vitro toxicity evaluation of a luciferase less susceptible to HPV chemical inhibition.

Kim-Choi E, Danilo C, Kelly J, Carroll R, Shonnard D, Rybina I.

Toxicol In Vitro. 2006 Dec;20(8):1537-47. Epub 2006 Jul 12.

PMID:
16962283
5.

Creating a mutant luciferase resistant to HPV chemical inhibition by random mutagenesis and colony-level screening.

Kim-Choi E, Danilo C, Kelly J, Carroll R, Shonnard D, Rybina I.

Luminescence. 2006 May-Jun;21(3):135-42.

PMID:
16502391
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk